[⁶⁸Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series

2024-9-12

Diagnostic Accuracy of [¹⁸F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Metaanalysis

2024-9-12

Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting

2024-9-12

Design, Synthesis, and Preclinical Evaluation of a High-Affinity¹⁸F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction

2024-9-12

Quantitative SPECT/CT Metrics in Early Prediction of [¹⁷⁷Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients

2024-9-12

Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECT

2024-9-12

Dual Somatostatin Receptor/¹⁸F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors

2024-9-12

Preclinical Evaluation of¹⁷⁷Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors

2024-9-12

Nuclear Imaging of Bispecific Antibodies on the Rise

2024-9-12

Development of¹⁸F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance

2024-9-12

The Translation of Dosimetry into Clinical Practice: What It Takes to Make Dosimetry a Mandatory Part of Clinical Practice

2024-9-5

First-in-Human Total-Body PET/CT Imaging Using⁸⁹Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma

2024-9-5

Evaluating the Utility of¹⁸F-FDG PET/CT in Cancer of Unknown Primary

2024-9-5

Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [¹⁸F]PSMA-1007 PET/CT

2024-9-5

C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [^99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study

2024-9-5

Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer

2024-9-5

Improving¹⁸F-FDG PET Quantification Through a Spatial Normalization Method

2024-8-29

Association Between CA 15-3 and¹⁸F-FDG PET/CT Findings in Recurrent Breast Cancer Patients at a Tertiary Referral Hospital in Kenya

2024-8-29

The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for¹⁶¹Tb Compared with¹⁷⁷Lu with a Higher Dose Response for [¹⁶¹Tb]Tb-DOTA-LM3 Than for [¹⁶¹Tb]Tb-DOTATATE

2024-8-29

Navigating the Future of Prostate Cancer Care: AI-Driven Imaging and Theranostics Through the Lens of RELAINCE

2024-8-29

1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?

2024-8-21

Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?

2024-8-14

Theranostic Intratumoral Convection-Enhanced Delivery of¹²⁴I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry

2024-8-14

Single Chelator–Minibody Theranostic Agents for⁸⁹Zr PET Imaging and¹⁷⁷Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer

2024-8-14

The Costs to Our Patients

2024-8-14

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up

2024-8-14

¹⁷⁷Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?

2024-8-8

[⁶⁸Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria

2024-8-8

Impact of Posttreatment SPECT/CT on Patient Management During¹⁷⁷Lu-PSMA-617 Radiopharmaceutical Therapy

2024-8-8

Neurologic Symptoms After¹⁷⁷Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience

2024-8-1

Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network

2024-8-1

¹⁸F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology

2024-8-1

Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer

2024-8-1

Utility of⁶⁴Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on⁶⁸Ga-PSMA-11 PET/CT

2024-8-1

Total-Body Dynamic Imaging and Kinetic Modeling of [¹⁸F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy

2024-8-1

International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline¹⁸F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation

2024-8-1

Role of⁶⁴CuCl₂PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and¹⁸F-FDG PET/CT

2024-7-25

Unrealistic Data Augmentation Improves the Robustness of Deep Learning–Based Classification of Dopamine Transporter SPECT Against Variability Between Sites and Between Cameras

2024-7-25

Reply; The Potential Value of Functional Adrenal Imaging in Primary Aldosterone

2024-7-25

The Potential Value of Functional Adrenal Imaging in Primary Aldosterone

2024-7-25

Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure

2024-7-25

Development of a²¹³Bi-Labeled Pyridyl Benzofuran for Targeted α-Therapy of Amyloid-β Aggregates

2024-7-25

Reply: Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions

2024-7-25

FINDing the Future of Radiopharma

2024-7-25

Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of²²⁵Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models

2024-7-25

Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions

2024-7-25

Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study

2024-7-18

<i>h</i>HEPATO-Cy5, a Bimodal Tracer for Image-Guided Hepatobiliary Surgery

2024-7-18

StepBrain: A 3-Dimensionally Printed Multicompartmental Anthropomorphic Brain Phantom to Simulate PET Activity Distributions

2024-7-18

²¹¹At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation

2024-7-18